2型糖尿病の世界市場規模調査＆予測：薬効クラス別、用途別、地域別分析、2023-2030年

2型糖尿病の世界市場は、2022年には約323億2,000万米ドルと評価され、予測期間2023-2030年には8.4%以上のCAGRで成長すると予測されています。

2型糖尿病は、成人発症糖尿病または非インスリン依存性糖尿病とも呼ばれ、高血糖を特徴とする慢性代謝疾患です。2型糖尿病は、診断された症例の約90～95％を占める最も一般的な糖尿病です。体内でインスリンが産生されない自己免疫疾患である1型糖尿病とは異なり、2型糖尿病はインスリン抵抗性と不十分なインスリン産生を特徴とします。糖尿病患者数の増加と老年人口の増加が、予測期間中の市場促進要因となっています。

世界保健機関（WHO）によると、糖尿病は2021年に世界で5億3,700万人の成人を苦しめる可能性があり、10人に1人がその他の糖尿病を経験しています。2022年の世界銀行グループによると、2020年の世界の高齢者人口は7億2,700万人で、今後30年間で増加し、2050年には15億人に達すると予測されています。しかし、病気に対する認識不足や、利用可能な治療オプションが限られていることが、この市場の成長余地を妨げる可能性があります。さらに、新興医薬品セクターと2型糖尿病有病率の増加が、2型糖尿病世界市場の成長を押し上げると予測されています。

2型糖尿病の世界市場調査において考慮された主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は2型糖尿病市場を独占しています。同地域の市場成長の原動力は糖尿病有病率の増加であり、2,900万人以上が罹患し、2025年には3,200万人に増加すると予測されています。特筆すべきは、米国だけでも2019年には2,500万人を超える糖尿病患者がいたことです。ヘルスケア部門の拡大、有利な政府規制、イニシアチブの増加と有利な償還政策が、北米の2型糖尿病市場全体の成長に寄与しています。欧州は地域の中で最も高い成長率を示すと予想されています。欧州内では、2型糖尿病市場は主に英国が支配的です。2型糖尿病患者数の増加が、同地域における市場成長の主な促進要因となっています。研究開発活動の活発化や肥満の有病率の上昇といった要因が、2型糖尿病治療薬の需要に寄与しています。さらに、サプライチェーン管理の強化は、欧州における2型糖尿病市場の拡大に有利な機会をもたらしています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界市場・セグメント別・市場推計・予測、2020-2030年
  • 2型糖尿病市場：地域別、2020-2030年
  • 2型糖尿病市場：薬剤クラス別、2020-2030年
  • 2型糖尿病市場：用途別、2020-2030年
• 主要動向
• 調査手法
• 調査前提条件

第2章 2型糖尿病の世界市場：定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の発展
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 2型糖尿病の世界市場力学

• 2型糖尿病市場の影響分析（2020-2030年）
  • 市場促進要因
    • 糖尿病患者数の増加
    • 高齢者人口の増加
  • 市場の課題
    • 疾患に対する認識不足
    • 限られた治療オプション
  • 市場機会
    • 新興医薬品セクター
    • 2型糖尿病の有病率の増加

第4章 2型糖尿病の世界市場：産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治的
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 2型糖尿病の世界市場：薬効クラス別

• 市場スナップショット
• 2型糖尿病の世界市場：薬物クラス別、実績- ポテンシャル分析
• 2型糖尿病の世界市場、薬効クラス別、推定・予測、2020-2030年
• 2型糖尿病市場、サブセグメント別分析
  • ジペプチジルペプチダーゼ-4阻害薬
  • グルカゴン様ペプチド
  • 受容体作動薬
  • チアゾリジン系薬剤
  • α-グルコシダーゼ阻害薬
  • スルホニル尿素およびその他の分泌促進薬
  • ビグアナイド薬
  • ナトリウムグルコース共輸送体2阻害薬

第6章 2型糖尿病の世界市場：用途別

• 市場スナップショット
• 2型糖尿病の世界市場：用途別、実績- ポテンシャル分析
• 2型糖尿病の世界市場：用途別、推定・予測、2020-2030年
• 2型糖尿病市場、サブセグメント別分析
  • 血糖コントロール
  • 心血管安全性
  • 低血糖回避
  • その他

第7章 2型糖尿病の世界市場、地域分析

• 主要国
• 主な新興国
• 2型糖尿病市場、市場スナップショット、地域別
• 北米
  • 米国
    • 薬剤クラスの推定・予測、2020-2030年
    • アプリケーションの推定・予測、2020-2030年
  • カナダ
• 欧州2型糖尿病市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋2型糖尿病市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの2型糖尿病市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第8章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Amgen Inc.
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Daiichi Sankyo Co. Ltd
  • Eli Lilly and Co.
  • Merck & Co. Inc
  • Novo Nordisk AS
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd
  • Novartis AG

第9章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Type 2 Diabetes Market, report scope
• TABLE 2. Global Type 2 Diabetes Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Type 2 Diabetes Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
• TABLE 4. Global Type 2 Diabetes Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 6. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. U.S. Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 17. U.S. Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. Canada Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 19. Canada Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. UK Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 22. UK Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. Germany Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 25. Germany Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. France Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 28. France Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. Italy Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 31. Italy Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Spain Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 34. Spain Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. RoE Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 37. RoE Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. China Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 40. China Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. India Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 43. India Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. Japan Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 46. Japan Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. South Korea Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 49. South Korea Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. Australia Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 52. Australia Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. RoAPAC Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. Brazil Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 58. Brazil Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Mexico Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 61. Mexico Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. RoLA Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 64. RoLA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. Saudi Arabia Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 67. South Africa Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. RoMEA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Type 2 Diabetes Market
• TABLE 70. List of primary sources, used in the study of global Type 2 Diabetes Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Type 2 Diabetes Market, research methodology
• FIG 2. Global Type 2 Diabetes Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Type 2 Diabetes Market, key trends 2022
• FIG 5. Global Type 2 Diabetes Market, growth prospects 2023-2030
• FIG 6. Global Type 2 Diabetes Market, porters 5 force model
• FIG 7. Global Type 2 Diabetes Market, pest analysis
• FIG 8. Global Type 2 Diabetes Market, value chain analysis
• FIG 9. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Type 2 Diabetes Market, regional snapshot 2020 & 2030
• FIG 15. North America Type 2 Diabetes Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Type 2 Diabetes Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Type 2 Diabetes Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Type 2 Diabetes Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Type 2 Diabetes Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

Global Type 2 Diabetes Market is valued approximately at USD 32.32 billion in 2022 and is anticipated to grow with a compounded annual growth rate of more than 8.4% over the forecast period 2023-2030. Type 2 Diabetes, also known as adult-onset diabetes or non-insulin-dependent diabetes is a chronic metabolic disorder characterized by high blood sugar levels. It is the most common form of diabetes accounting for approximately 90% to 95% of all diagnosed cases. Unlike type one diabetes, which is an autoimmune condition where the body fails to produce insulin type two diabetes is characterized by insulin resistance and inadequate insulin production. Increasing number of diabetic patients and growing geriatric population elucidate as the growth drivers of this market during the forecast period.

According to the World Health Organization, diabetes may afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. According to the World Bank Group in 2022, the world old population was 727 million in 2020, and it is predicted to rise over the next three decades, reaching 1.5 billion in 2050. However, lack of awareness of disease and limited treatment options availability may hamper the growth space of this market. Furthermore, emerging pharma sector and increasing prevalence of type 2 diabetes anticipated to elevate the growth of the Global Type 2 Diabetes Market.

The key regions considered for the Global Type 2 Diabetes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the type 2 diabetes market. The region's market growth is driven by the increasing prevalence of diabetes, with over 29 million individuals affected, expected to rise to 32 million by 2025. Notably, the United States alone had more than 25 million diabetic patients in 2019. The expansion of the healthcare sector, favorable government regulations, and a growing number of initiatives and favorable reimbursement policies contribute to the overall growth of the type 2 diabetes market in North America. Europe is anticipated to exhibit the highest growth rate among regions. Within Europe, the type 2 diabetes market is primarily dominated by the United Kingdom. The increasing number of patients with type 2 diabetes is a key driver for market growth in the region. Factors such as escalating research and development activities and the rising prevalence of obesity contribute to the demand for type 2 diabetes drugs. Furthermore, enhanced supply chain management presents favorable opportunities for the expansion of the type 2 diabetes market in Europe.

Major market players included in this report are:

• Amgen Inc.
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co. Ltd
• Eli Lilly and Co.
• Merck & Co. Inc
• Novo Nordisk AS
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd
• Novartis AG

Recent Developments in the Market:

• In October 2022, Glenmark Pharmaceuticals introduced a novel medication called Zita D, intended for the treatment of patients with type 2 diabetes, particularly those who also have a comorbid condition.
• In March 2019, Novo Nordisk announced its plans to invest approximately USD 98 million in the expansion and advancement of its insulin medicine manufacturing facility located in Denmark. The completion of this project is anticipated to occur by the conclusion of 2020.

Global Type 2 Diabetes Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Drug Class, Application, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

• Dipeptidyl Peptidase-4 Inhibitors
• Glucagon-Like Peptide Receptor Agonists
• Thiazolidinediones
• Alpha-Glucosidase Inhibitors
• Sulfonylureas & Other Insulin Secretagogues
• Biguanides
• Sodium Glucose Cotransport 2 Inhibitors

By Application:

• Glycaemic Control
• Cardiovascular Safety
• Hypoglycaemia Avoidance
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Type 2 Diabetes Market, by region, 2020-2030 (USD Billion)
  • 1.2.2. Type 2 Diabetes Market, by Drug Class, 2020-2030 (USD Billion)
  • 1.2.3. Type 2 Diabetes Market, by Application, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Type 2 Diabetes Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Type 2 Diabetes Market Dynamics

• 3.1. Type 2 Diabetes Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing Number of Diabetes Patients
    • 3.1.1.2. Growing Geriatric Population
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of Awareness of Disease
    • 3.1.2.2. Limited Treatment Options Available
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Emerging Pharma Sector
    • 3.1.3.2. Increasing Prevalence of Type 2 Diabetes

Chapter 4. Global Type 2 Diabetes Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Type 2 Diabetes Market, by Drug Class

• 5.1. Market Snapshot
• 5.2. Global Type 2 Diabetes Market by Drug Class, Performance - Potential Analysis
• 5.3. Global Type 2 Diabetes Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
• 5.4. Type 2 Diabetes Market, Sub Segment Analysis
  • 5.4.1. Dipeptidyl Peptidase-4 Inhibitors
  • 5.4.2. Glucagon-Like Peptide
  • 5.4.3. Receptor Agonists
  • 5.4.4. Thiazolidinediones
  • 5.4.5. Alpha-Glucosidase Inhibitors
  • 5.4.6. Sulfonylureas and other Secretagogues
  • 5.4.7. Biguanides
  • 5.4.8. Sodium Glucose Cotransport 2 Inhibitors

Chapter 6. Global Type 2 Diabetes Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Type 2 Diabetes Market by Application, Performance - Potential Analysis
• 6.3. Global Type 2 Diabetes Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Type 2 Diabetes Market, Sub Segment Analysis
  • 6.4.1. Glycaemic Control
  • 6.4.2. Cardiovascular Safety
  • 6.4.3. Hypoglycaemia Avoidance
  • 6.4.4. Others

Chapter 7. Global Type 2 Diabetes Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Type 2 Diabetes Market, Regional Market Snapshot
• 7.4. North America Type 2 Diabetes Market
  • 7.4.1. U.S. Type 2 Diabetes Market
    • 7.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Type 2 Diabetes Market
• 7.5. Europe Type 2 Diabetes Market Snapshot
  • 7.5.1. U.K. Type 2 Diabetes Market
  • 7.5.2. Germany Type 2 Diabetes Market
  • 7.5.3. France Type 2 Diabetes Market
  • 7.5.4. Spain Type 2 Diabetes Market
  • 7.5.5. Italy Type 2 Diabetes Market
  • 7.5.6. Rest of Europe Type 2 Diabetes Market
• 7.6. Asia-Pacific Type 2 Diabetes Market Snapshot
  • 7.6.1. China Type 2 Diabetes Market
  • 7.6.2. India Type 2 Diabetes Market
  • 7.6.3. Japan Type 2 Diabetes Market
  • 7.6.4. Australia Type 2 Diabetes Market
  • 7.6.5. South Korea Type 2 Diabetes Market
  • 7.6.6. Rest of Asia Pacific Type 2 Diabetes Market
• 7.7. Latin America Type 2 Diabetes Market Snapshot
  • 7.7.1. Brazil Type 2 Diabetes Market
  • 7.7.2. Mexico Type 2 Diabetes Market
• 7.8. Middle East & Africa Type 2 Diabetes Market
  • 7.8.1. Saudi Arabia Type 2 Diabetes Market
  • 7.8.2. South Africa Type 2 Diabetes Market
  • 7.8.3. Rest of Middle East & Africa Type 2 Diabetes Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Amgen Inc.
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. AstraZeneca PLC
  • 8.3.3. Boehringer Ingelheim International GmbH
  • 8.3.4. Daiichi Sankyo Co. Ltd
  • 8.3.5. Eli Lilly and Co.
  • 8.3.6. Merck & Co. Inc
  • 8.3.7. Novo Nordisk AS
  • 8.3.8. Sanofi SA
  • 8.3.9. Takeda Pharmaceutical Co. Ltd
  • 8.3.10. Novartis AG

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption